Literature DB >> 3497468

Lack of immune deficiency in sarcoidosis: compartmentalisation of the immune response.

B N Hudspith, K C Flint, D Geraint-James, J Brostoff, N M Johnson.   

Abstract

The original findings of peripheral anergy in sarcoidosis led to the conclusion that sarcoidosis was a disease associated with immune deficiency, but patients with sarcoidosis do not appear to suffer from repeated infections suggestive of immune suppression. With the technique of bronchoalveolar lavage it is now possible to examine the local immune response within the lung, the most commonly affected organ in sarcoidosis. In this study three different indices of cell mediated immunity (lymphocyte transformation, interleukin-2 production, and interleukin-1 production) have been examined by comparison of cells recovered by lavage with those collected from peripheral blood. It was found that in vitro anergy was confined to peripheral blood cells, where all three markers of the immune response used in this study was impaired in the 12 patients with sarcoidosis group when compared with results in the 12 controls, with the most depressed responses seen in those patients classified as having active disease (lymphocyte proliferation 45% (SD 17%); interleukin-2 production 44% (13%), and interleukin-1 production 31% (10%) of control levels). By contrast, T lymphocytes recovered from the lungs of patients with sarcoidosis showed a greater response than did those from controls in terms of lymphocyte transformation and interleukin-2 production; these differences were greatest in those with active disease (lymphocyte proliferation 209% (27%) and interleukin-2 production 202% (19%) of control levels). Interleukin-1 production by cells of the monocyte lineage recovered from the lung gave similar results to those of the control and sarcoid groups. It is concluded that the anergy seen in the peripheral blood compartment possibly reflects redistribution of T lymphocytes rather than a generalised immune deficiency.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497468      PMCID: PMC460694          DOI: 10.1136/thx.42.4.250

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  10 in total

1.  Correlation of tuberculin-induced lymphocyte transformation with skin test reactivity and with clinical manifestations of sarcoidosis.

Authors:  M Horsmanheimo
Journal:  Cell Immunol       Date:  1974-03-15       Impact factor: 4.868

2.  Localization of the immune response in sarcoidosis.

Authors:  G W Hunninghake; J D Fulmer; R C Young; J E Gadek; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1979-07

3.  Suppressor cell function in sarcoidosis.

Authors:  J S Goodwin; R DeHoratius; H Israel; G T Peake; R P Messner
Journal:  Ann Intern Med       Date:  1979-02       Impact factor: 25.391

4.  The alveolitis of pulmonary sarcoidosis. Evaluation of natural history and alveolitis-dependent changes in lung function.

Authors:  B A Keogh; G W Hunninghake; B R Line; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1983-08

5.  Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.

Authors:  G W Hunninghake
Journal:  Am Rev Respir Dis       Date:  1984-04

6.  Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis.

Authors:  P Pinkston; P B Bitterman; R G Crystal
Journal:  N Engl J Med       Date:  1983-04-07       Impact factor: 91.245

7.  Impaired production of interleukins in patients with cell-mediated immunodeficiencies.

Authors:  R Paganelli; F Aiuti; P C Beverley; R J Levinsky
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

8.  Pulmonary sarcoidosis: alterations in bronchoalveolar lymphocytes and T cell subsets.

Authors:  A P Greening; P Nunn; N Dobson; M Rudolf; A D Rees
Journal:  Thorax       Date:  1985-04       Impact factor: 9.139

9.  Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung.

Authors:  G W Hunninghake; J E Gadek; R C Young; O Kawanami; V J Ferrans; R G Crystal
Journal:  N Engl J Med       Date:  1980-03-13       Impact factor: 91.245

10.  Anergy in sarcoidosis: the role of interleukin-1 and prostaglandins in the depressed in vitro lymphocyte response.

Authors:  B N Hudspith; J Brostoff; M W McNicol; N M Johnson
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

  10 in total
  9 in total

1.  Analysis of CD4-positive T cell subpopulation in sarcoidosis.

Authors:  R Gerli; S Darwish; L Broccucci; V Minotti; F Spinozzi; C Cernetti; A Bertotto; P Rambotti
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

2.  Serum C-reactive protein concentrations in patients with pulmonary sarcoidosis.

Authors:  C R Hind; K C Flint; B N Hudspith; D Felmingham; J Brostoff; N M Johnson
Journal:  Thorax       Date:  1987-05       Impact factor: 9.139

3.  Differential expression of microRNA and predicted targets in pulmonary sarcoidosis.

Authors:  Elliott D Crouser; Mark W Julian; Melissa Crawford; Guohong Shao; Lianbo Yu; Stephen R Planck; James T Rosenbaum; S Patrick Nana-Sinkam
Journal:  Biochem Biophys Res Commun       Date:  2011-12-24       Impact factor: 3.575

4.  Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis.

Authors:  Laura L Koth; Owen D Solberg; Jeffrey C Peng; Nirav R Bhakta; Christine P Nguyen; Prescott G Woodruff
Journal:  Am J Respir Crit Care Med       Date:  2011-08-18       Impact factor: 21.405

5.  Evaluation of soluble CD 14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis.

Authors:  J Homolka; J Lorenz; H D Zuchold; J Müller-Quernheim
Journal:  Clin Investig       Date:  1992-10

6.  Impaired non-specific delayed cutaneous hypersensitivity in bird fancier's lung.

Authors:  R Orriols; F Morell; V Curull; A Roman; G Sampol
Journal:  Thorax       Date:  1989-02       Impact factor: 9.139

7.  Increased CD45RO expression on T lymphocytes in mediastinal lymph node and pulmonary lesions of patients with pulmonary sarcoidosis.

Authors:  S B Fazel; S E Howie; A S Krajewski; D Lamb
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

8.  Increased interleukin 6 production by bronchoalveolar lavage cells in patients with active sarcoidosis.

Authors:  J Homolka; J Müller-Quernheim
Journal:  Lung       Date:  1993       Impact factor: 2.584

9.  Imbalance of pro- and anti-inflammatory cytokines in pulmonary sarcoidosis.

Authors:  J Müller-Quernheim
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.